banner
   
Search

Only search Equitap
Hong Kong SAR

The Hong Kong SAR is one of the highest income economies in the world. In relative terms, Hong Kong’s health system has proved remarkably successful with respect to population health, cost containment, avoidance of catastrophic medical expenditure risks, and the targeting of public health spending on the poor. However, like other developed economies, Hong Kong faces the challenges of an ageing population as a result of sustained low fertility rate, and an increasingly high burden of chronic diseases punctuated by low probability, high impact infectious disease outbreaks. Hong Kong was covered in Equitap 1, and these results are being updated in Equitap 2.

Equitap analysis

Equitap 1
Completed
Progressivity of financing, Healthcare utilization, Benefit incidence analysis, Catastrophic impacts, Impoverishment, Public opinions on equity, Equity in policy frameworks
Equitap 2
Ongoing
Progressivity of financing, Healthcare utilization, Benefit incidence analysis, Catastrophic impacts, Impoverishment, Public opinions on equity, Equity in policy frameworks

 

Equitap team
Mr. Keith YK Tin
Prof. Gabriel M. Leung (on leave) 

Contact details
5F William MW Mong Block,
Faculty of Medicine Building
21 Sassoon Road, Hong Kong.

URL:http://sph.hku.hk/index.php

Phone:+ 852-2819-9280

Fax: + 852-2855-9528

The School of Public Health, University of Hong Kong (HKU) has a long and distinguished record in providing teaching, research, and consultancy services in the fields of public health, health services research, epidemiology, health policy and economics, and behavioural sciences.  More info>>